Abstract:The human body is home to a variety of micro-organisms. Most of these microbial communities reside in the gut and are referred to as gut microbiota. Over the last decades, compelling evidence showed that a number of human pathologies are associated with microbiota dysbiosis, thereby suggesting that the reinstatement of physiological microflora balance and composition might ameliorate the clinical symptoms. Among possible microbiota-targeted interventions, pre/pro-biotics supplementations were shown to provide effective results, but the main limitation remains in the limited microbial species available as probiotics. Differently, fecal microbiota transplantation involves the transplantation of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient's gut microbial composition aiming to confer a health benefit. Firstly used in the 4th century in traditional Chinese medicine, nowadays, it has been exploited so far to treat recurrent Clostridioides difficile infections, but accumulating data coming from a number of clinical trials clearly indicate that fecal microbiota transplantation may also carry the therapeutic potential for a number of other conditions ranging from gastrointestinal to liver diseases, from cancer to inflammatory, infectious, autoimmune diseases and brain disorders, obesity, and metabolic syndrome. In this review, we will summarize the commonly used preparation and delivery methods, comprehensively review the evidence obtained in clinical trials in different human conditions and discuss the variability in the results and the pivotal importance of donor selection. The final aim is to stimulate discussion and open new therapeutic perspectives among experts in the use of fecal microbiota transplantation not only in Clostridioides difficile infection but as one of the first strategies to be used to ameliorate a number of human conditions.

The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome

Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation

Roles of the gut virome and mycobiome in faecal microbiota transplantation

Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases

Fecal virome transplantation: A promising strategy for the treatment of metabolic diseases

Fecal microbiota transplantation: current challenges and future landscapes

Fecal Microbiota Transplantation: Indications, Methods, and Challenges

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies

Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns

Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives

Fecal microbiota transplantation: in perspective

An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases

Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation

Fecal Microbiota Transplantation: An Update on Clinical Practice

Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products

Clinical Application and Potential of Fecal Microbiota Transplantation

Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies

Fecal microbiota transplantation and emerging applications

Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions